How do I calculate the total body surface area involvement in Stevens‑Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Calculate Total Body Surface Area (TBSA) in SJS/TEN

In SJS/TEN, you must calculate and document TWO separate measurements using the Lund and Browder chart: (1) the percentage of body surface area with erythema, and (2) the percentage with epidermal detachment—it is the detachment figure, not erythema, that determines disease classification, prognosis, and management decisions. 1, 2

What to Measure and Why

The Critical Distinction: Erythema vs. Detachment

  • Record the extent of erythema separately from epidermal detachment on a body map 1, 2
  • The percentage of epidermal detachment has prognostic value, while erythema alone does not 1, 2
  • Epidermal detachment includes:
    • Already detached epidermis (visible erosions and blisters) 2
    • Detachable epidermis (areas with positive Nikolsky sign—where gentle lateral pressure causes the epidermis to slide over the dermis) 2, 3

Disease Classification Based on Detachment Percentage

The British Association of Dermatologists guidelines define three categories based solely on the extent of epidermal detachment 1, 2:

  • SJS: <10% BSA epidermal detachment plus widespread purpuric macules or flat atypical targets 2, 3
  • SJS-TEN overlap: 10-30% BSA detachment plus widespread purpuric macules or flat atypical targets 2, 3
  • TEN: >30% BSA detachment with or without widespread purpuric macules or target lesions 2, 3

Step-by-Step Calculation Method

Use the Lund and Browder Chart

  • The Lund and Browder chart is the recommended tool for estimating the percentage of BSA involved 1
  • This chart accounts for age-related variations in body proportions, making it more accurate than the "rule of nines" (particularly important in pediatric cases) 1

Documentation Process

  1. Perform a complete physical examination of the skin, looking for target lesions, purpuric macules, blisters, and areas of epidermal detachment 1
  2. Create a body map marking two distinct parameters 1:
    • Areas of erythema (in one color)
    • Areas of epidermal detachment (in another color)
  3. For epidermal detachment, include:
    • Visible denuded areas where epidermis has already separated 2
    • Areas where the Nikolsky sign is positive (detachable but not yet separated epidermis) 2
  4. Calculate the percentage for each parameter using the Lund and Browder chart 1

Clinical Application and Pitfalls

Why This Matters for Management

  • Patients with >10% BSA epidermal detachment require immediate transfer to a burn center or ICU with SJS/TEN experience 2
  • The detachment percentage is used in the SCORTEN scoring system to predict mortality 2
  • Wound management approach differs based on extent: conservative for limited detachment, surgical for >30% BSA with clinical deterioration 2

Common Pitfalls to Avoid

  • Do not use erythema percentage for classification—only the detachment figure determines whether a patient has SJS, overlap, or TEN 1, 2
  • Do not overlook detachable epidermis—areas with positive Nikolsky sign must be included in your detachment calculation even if the epidermis hasn't visibly separated yet 2
  • Reassess progression—monitor for increasing detachment, as this indicates worsening disease and may change management 2
  • Document both measurements within 24 hours of diagnosis to establish baseline and guide prognostic discussions 1

Practical Example

A patient may have 65% BSA with erythema but only 10% BSA with actual epidermal detachment 1. This patient would be classified as SJS-TEN overlap (based on the 10% detachment), not TEN, despite the extensive erythema. The 10% detachment figure is what determines transfer decisions, SCORTEN calculation, and treatment intensity 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What medications are most commonly associated with Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)?
What is the clinical diagnosis and management approach for a patient presenting with symptoms of Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), including recent medication use or infections?
What disorder is most commonly associated with Stevens-Johnson syndrome?
What to do if Coamoxiclav (amoxicillin/clavulanic acid) is suspected to cause Stevens-Johnson Syndrome (SJS)?
What is the difference between Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)?
A 70‑year‑old ex‑smoker (30‑year smoking history, quit 5 years ago) with a productive cough, negative tuberculosis work‑up, who improved for 5 days on N‑acetylcysteine 600 mg twice daily and ambroxol syrup but now has recurrence—what are the likely differential diagnoses and recommended management?
What mutations have been reported in hereditary spherocytosis?
What is the recommended fluid management protocol for a 70‑kg adult with 30 % total body surface area involvement due to toxic epidermal necrolysis?
Why should a lipid profile be performed after an 8‑ to 12‑hour fast?
When is volume‑assured pressure therapy indicated for adults with obstructive sleep apnea who have persistent apnea‑hypopnea index >5 despite maximal CPAP (≥15 cm H₂O), nocturnal hypoventilation/hypercapnia (e.g., obesity‑hypoventilation, COPD‑OSA overlap, neuromuscular disease), emergent central or mixed apneas on high CPAP, or intolerance to high inspiratory pressures?
Can a febrile adult patient be started on a blood transfusion before the cause of the fever is identified?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.